Please assess the completion status of the following clinical trial:

Trial Title: Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Willing to provide a written informed consent prior to receiving any study-specific procedures or assessments.~* Diagnosed with a solid malignant tumor and has not previously received chemotherapy.~* Scheduled to receive chemotherapy conducive to regimens outlined in the study protocol.~Exclusion criteria:~* Not received any investigational product within 30 days of enrollment into the study.~* Must not be pregnant.~* Must not be of childbearing potential or is willing to use specific barrier methods outlined in the protocol.~* Must not be scheduled to receive radiation therapy to the abdomen or to the pelvis within seven (7) days prior to starting study medication.~* Must not be currently under treatment for a condition which may cause nausea or vomiting (i.e., active peptic ulcer disease, gastric obstruction).~* Must not have a history of peptic ulcer disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).